The historical stock prices of these companies were obtained from the following two excellent internet resources.... Google Finance and MarketWatch Big Charts. The superb Yahoo Finance website was also utilized heavily.
Of these 27 US IPOs in only the first two months of 2014, 10 are Biotechs, 4 are Health Care other than Biotechs, only 1 is Technology, 4 are Oil & Gas, 3 are Financials, 3 are Industrial Goods and 2 are in Other Sectors.
These 27 US Companies with IPOs in the first two months of 2014 posted an average stock market price increase of an incredibly off-the-charts 28% in the extremely short period of time from the end of the first day the Company's common stock started trading through March 11, 2014. As a comparison, the S&P 500 Index is up only 1% from the December 31, 2013 to March 11, 2014.
The Health Care Sector again led the stock price appreciation upward explosion.
The 10 US Biotechs with IPOs in just the first two months of 2014 had an average stock market price increase of a spectacularly off-the-charts 42% in the extremely short period of time through March 11, 2014. Whew!
Incredibly, 8 of the 10 Biotechs had stock market price appreciation above 30% for the extremely short period of time in 2014 through March 11, 2014. Another Whew!
Two of the Biotechs.....GlycoMimetics and Genocea Biosciences.....had stock market price appreciation of at least 80% in this very short period of time through March 11, 2014.
There were 30 US Biotech IPOs for all of 2013, but only 1 in the first two months of 2013.....versus 10 in the first two months of 2014. With this incredible stock price appreciation, it is easy to see why.
The 4 Health Care Companies other than the 10 US Biotechs with IPOs in just the first two months of 2014 had an average stock market price increase which was also a spectacularly off-the-charts 39% in the extremely short period of time through March 11, 2014. Auspex Pharmaceuticals had stock market price appreciation of 91%, which was even higher than that of any of the 10 Biotechs. And the worst performer of the 4 had a very impressive stock market price appreciation of 10% for this extremely short period of time.
Yeah, Obamacare is just killing Health Care Companies. Give me a break!
The 3 US Industrial Goods Companies.....all 3 connected with the Construction Industry.....with IPOs in just the first two months of 2014 had an average stock market price increase of an exceptional 23% in the extremely short period of time through March 11, 2014.
The 4 US Oil & Gas Companies with IPOs in just the first two months of 2014 had an average stock market price increase of an very impressive 14% in the extremely short period of time through March 11, 2014. Yeah, that's up 14% versus the S&P 500 Index being up only 1% so far this year through March 11, 2014.
There were even two Companies in Other Sectors filing IPOs and having exceptional stock price appreciation through March 11, 2014..... Malibu Boats up 25% and Intrawest Resorts up 17%.
Yeah, Obama is the IPO President. I think he should consider fundraising every month for US Senate Candidates with the Biotech Industry and smart people who have invested in Biotech Stocks....but not campaign for the US House, until it cleans House.....some of these DCCC people and some of the local Democratic Party people at the House District level are just so incompetent.....if you give them money, you are just throwing your money away.
It's easy for me to see why the Democrats don't have control of the US House. Redistricting is a minor reason compared to the utter incompetence of some of the DCCC and some of the local Democratic Party people at the District level.
If a well-run US business has an employee in a very key position and that person is continually making mistakes that are seriously harming the business, then it logically replaces him.
But not the Democrats. They permit the loyal, nice but clearly incompetent employee to remain in his very key job that is seriously harming both the Democratic Party and the country. It's a crazy but also a losing strategy and explains why a superb past Speaker of the House like Nancy Pelosi hasn't been the Speaker of the House for a long time. And she won't be until the Democratic Party does the right thing and replace all of these incompetent people at both the DCCC and in key leadership positions in many local Democratic Districts. Just sayin.
Below here are the stock market prices of these 27 US Companies having IPOs in the first two months of 2014 on March 11, 2014 and also on the first day IPO closing market price in 2014, along with the related % Change for this extremely short period of time:
| 1st Day | ||||||
| IPO | ||||||
| 2014 | 3-11-14 | Closing | ||||
| IPO | Market | Market | % | |||
| Date | Company | Sector | Industry | Price | Price | Change |
| Biotechnology | ||||||
| 1/10/14 | GlycoMimetics | Health Care | Biotechnology | $16.88 | $9.01 | 87% |
| 2/5/14 | Genocea Biosciences | Health Care | Biotechnology | $19.77 | $11.00 | 80% |
| 1/31/14 | Cara Therapeutics | Health Care | Biotechnology | $20.07 | $12.91 | 55% |
| 1/30/14 | Celladon | Health Care | Biotechnology | $12.27 | $8.18 | 50% |
| 1/31/14 | Ultragenyx Pharmaceutical | Health Care | Biotechnology | $62.38 | $42.25 | 48% |
| 1/31/14 | Trevena | Health Care | Biotechnology | $9.29 | $6.50 | 43% |
| 2/7/14 | Argos Therapeutics | Health Care | Biotechnology | $10.89 | $8.00 | 36% |
| 2/6/14 | Revance Therapeutics | Health Care | Biotechnology | $35.26 | $26.85 | 31% |
| 2/13/14 | Concert Pharmaceuticals | Health Care | Biotechnology | $15.08 | $14.18 | 6% |
| 1/30/14 | Dicerna Pharmaceuticals | Health Care | Biotechnology | $38.37 | $46.00 | -17% |
| Average % Change all 10 Biotechs | 42% | |||||
| Other Health Care | ||||||
| 2/5/14 | Auspex Pharmaceuticals | Health Care | Major Drug Manufacturers | $29.88 | $15.66 | 91% |
| 2/12/14 | Flexion Therapeutics | Health Care | Major Drug Manufacturers | $19.29 | $14.71 | 31% |
| 2/14/14 | Inogen | Health Care | Medical Instruments&Supplies | $18.75 | $15.15 | 24% |
| 2/12/14 | Eagle Pharmaceuticals | Health Care | Generic Drugs | $14.17 | $12.83 | 10% |
| Average % Change all 4 Other Health Care | 39% | |||||
| Technology | ||||||
| 2/28/14 | Varonis Systems | Technology | Business Software | $44.54 | $44.00 | 1% |
| Oil & Gas | ||||||
| 1/17/14 | RSP Permian | Basic Materials | Oil&Gas Drilling&Exploration | $26.50 | $20.15 | 32% |
| 1/24/14 | Rice Energy | Basic Materials | Independent Oil & Gas | $24.32 | $21.90 | 11% |
| 1/15/14 | Cypress Energy Partners, L.P. | Basic Materials | Oil&Gas Equip&Services | $23.39 | $21.30 | 10% |
| 1/17/14 | EP Energy | Basic Materials | Major Integrated Oil&Gas | $19.01 | $18.08 | 5% |
| Average % Change all 4 Oil & Gas | 14% | |||||
| Industrial Goods | ||||||
| 2/5/14 | Continental Building Products | Industrial Goods | General Building Materials | $19.90 | $15.19 | 31% |
| 1/31/14 | New Home Company (The) | Industrial Goods | Residential Construction | $14.77 | $12.20 | 21% |
| 2/13/14 | Installed Building Products | Industrial Goods | General Building Materials | $14.89 | $12.80 | 16% |
| Average % Change all 3 Industrial Goods | 23% | |||||
| Financial | ||||||
| 2/6/14 | Ladder Capital | Financial | Commercial Real Estate | $18.75 | $16.99 | 10% |
| 2/12/14 | Talmer Bancorp | Financial | Bank | $13.64 | $13.80 | -1% |
| 1/23/14 | Santander Consumer USA Holdings | Financial | Mortgage Investment | $23.94 | $25.28 | -5% |
| Average % Change all 3 Financial | 1% | |||||
| Other Sectors | ||||||
| 1/31/14 | Malibu Boats | Consumer Goods | Sport Boats | $22.24 | $17.75 | 25% |
| 1/31/14 | Intrawest Resorts Holdings | Services | General Entertainment | $13.97 | $11.90 | 17% |
| Average % Change all 2 Other Sectors | 21% | |||||
| Average % Change all 27 | 28% | |||||
